3-(ANILINO)-2-[3-(3-ALKOXY-PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER
3-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4H- pyrrolo[3,2-c]pyridin-4-one derivatives of formula (I) as EGFR inhibitors for the treatment of cancer. L'invention concerne des dérivées de 3-(anilino)-2-[3-(3-alcoxy-pyridin-4-yl]-1,5,6,7-tétrahydro-4H-pyrrolo [3,2-c] pyridin-4-on...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | 3-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4H- pyrrolo[3,2-c]pyridin-4-one derivatives of formula (I) as EGFR inhibitors for the treatment of cancer.
L'invention concerne des dérivées de 3-(anilino)-2-[3-(3-alcoxy-pyridin-4-yl]-1,5,6,7-tétrahydro-4H-pyrrolo [3,2-c] pyridin-4-one de formule (I) en tant qu'inhibiteurs de EGFR pour le traitement du cancer. |
---|